A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human Insulin

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

December 31, 1999

Study Completion Date

December 31, 1999

Conditions

DiabetesHealthy

Interventions

DRUG

insulin detemir

Given as intravenous infusion (i.v.) over a period of 8 hours during euglycaemic clamp

DRUG

human soluble insulin

Given as intravenous infusion (i.v.) over a period of 8 hours during euglycaemic clamp

Trial Locations (1)

Graz